- Institution
- 전북특별자치도 전주시
- Department
- 건강증진과
◎희귀질환자 의료비 지원
Programme 희귀질환자 의료비 지원
Amounts and period
- Budgeted amount
- 665,676,000 KRW
- 전년도예산액
- Present in the source but not extracted
- Change
- Not comparable
Changes are calculated only when both amounts are known in full. No percentage is calculated when the comparison amount is zero.
Programme hierarchy and share
The selected item’s share of each parent budget, calculated from amounts in the same source document.
A share is not calculated for missing or partial amounts, non-positive parent amounts, or an item amount greater than its parent.
-
Department 건강증진과 7,527,809,000 KRW8.8%
-
Policy 질병없는 건강도시 기반구축 6,873,831,000 KRW9.7%
-
Programme 건강지원 2,722,876,000 KRW24.4%
-
Project 희귀질환자 의료비 지원 665,676,000 KRW100.0%
-
Budget category 자치단체등이전 665,676,000 KRW100.0%
-
Statistical item 공기관등에대한경상적위탁사업비 665,676,000 KRW100.0%
-
Item ◎희귀질환자 의료비 지원 665,676,000 KRW
- Category–statistical code
- 308-13
- Group
- Not provided in source
Original description
Not provided in source
Institution and programme names are shown as the original Korean source text.
Detailed budget items
1 itemsData source
- Document ID
doc_5xaemg4g8h4x276k0e1jcsa4mx- Source document status
- Available
- File type
- application/pdf
- File size
- 235.142 KiB
- Location inside the source
- Page 19 Row 7 Line 2 Column level4
Source and reference
FY 2026 release No source record
- Fiscal year of record
- 2026
- Fetched from the source
- 2026-08-09 02:50
- Read and interpreted
- 2026-08-09 02:50
- Query snapshot refreshed
- 2026-09-02 03:23
- Item ID
bi_4p4xt04f0p1fbne489e8x4f3kk- Address of this item
- /en/BudgetDetail/Item/bi_4p4xt04f0p1fbne489e8x4f3kk
Related records
Similar budgets
5 itemsKeyword “희귀질환자” · classification 308-13
- ○희귀질환자 의료비 지원(8명) 1,000,000 KRW
- ◎희귀질환자 의료비 지원 665,676,000 KRW
- ○ 희귀질환자 의료비 지원 1,000,000 KRW
- ○ 희귀질환자 의료비 지원 37,105,000 KRW
- ◎희귀질환자 의료비 419,029,000원 419,029,000 KRW +122.5%
These items were verified within a limited set of name search results.
AI analysis report
AI analysis reports are not yet available.